Scientific article
Open access

Mycoplasma pneumoniae detections before and during the COVID-19 pandemic : results of a global survey, 2017 to 2021

CollaboratorsWagner, Noémie
Published inEurosurveillance, vol. 27, no. 19, 2100746
Publication date2022-05

BackgroundMycoplasma pneumoniaerespiratory infections are transmitted by aerosol and droplets in close contact.AimWe investigated globalM. pneumoniaeincidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March 2020.MethodsWe surveyedM. pneumoniaedetections from laboratories and surveillance systems (national or regional) across the world from 1 April 2020 to 31 March 2021 and compared them with cases from corresponding months between 2017 and 2020. Macrolide-resistantM. pneumoniae(MRMp) data were collected from 1 April 2017 to 31 March 2021.ResultsThirty-seven sites from 21 countries in Europe, Asia, America and Oceania submitted valid datasets (631,104 tests). Among the 30,617M. pneumoniaedetections, 62.39% were based on direct test methods (predominantly PCR), 34.24% on a combination of PCR and serology (no distinction between methods) and 3.37% on serology alone (only IgM considered). In all countries,M. pneumoniaeincidence by direct test methods declined significantly after implementation of NPIs with a mean of 1.69% (SD ± 3.30) compared with 8.61% (SD ± 10.62) in previous years (p < 0.01). Detection rates decreased with direct but not with indirect test methods (serology) (-93.51% vs + 18.08%; p < 0.01). Direct detections remained low worldwide throughout April 2020 to March 2021 despite widely differing lockdown or school closure periods. Seven sites (Europe, Asia and America) reported MRMp detections in one of 22 investigated cases in April 2020 to March 2021 and 176 of 762 (23.10%) in previous years (p = 0.04).ConclusionsThis comprehensive collection ofM. pneumoniaedetections worldwide shows correlation between COVID-19 NPIs and significantly reduced detection numbers.

  • Face masks
  • Mycoplasma pneumoniae
  • Nonpharmaceutical interventions (NPIs)
  • Personal protective equipment (PPE)
  • Pneumonia
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • COVID-19 / epidemiology
  • Communicable Disease Control
  • Humans
  • Macrolides
  • Mycoplasma pneumoniae / genetics
  • Pandemics
  • Pneumonia, Mycoplasma / diagnosis
  • Pneumonia, Mycoplasma / epidemiology
Citation (ISO format)
MEYER SAUTEUR, Patrick M et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic : results of a global survey, 2017 to 2021. In: Eurosurveillance, 2022, vol. 27, n° 19, p. 2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746
Main files (1)
Article (Published version)
ISSN of the journal1025-496X

Technical informations

Creation09/18/2023 7:30:06 AM
First validation12/15/2023 10:21:25 AM
Update time12/15/2023 10:21:25 AM
Status update12/15/2023 10:21:25 AM
Last indexation05/06/2024 5:36:43 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack